Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“FDA officials told the GAO that the lack of a written definition of "potential for abuse" presented challenges for determining the relative abuse potential and appropriate schedule recommendation for some substances.”
UnverifiableConfidence: LOW

Reasoning

The Reason.com article cites the GAO report stating that the Controlled Substances Act lacks a statutory definition of "potential for abuse" and that FDA officials reported this absence created challenges in assessing abuse potential and schedule recommendations. This matches the claim word‑for‑word.

On confidence: The claim is directly quoted in the provided source, which cites GAO findings and FDA officials' statements.

Important context

The statement reflects testimony to the GAO and highlights a recognized gap in the legal framework for drug scheduling.

Evidence

Supporting (1)

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    marijuana's abuse potential. The CSA "does not include a statutory definition of 'potential for abuse,'" the GAO notes, and "FDA officials told us that the lack of a written definition…presented challenges for determining the relative…

Limitations

The evidence is limited to a single secondary source summarizing the GAO report; the original GAO document was not directly accessed. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 1, 2026, 4:49 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum